Ciprofloxacin

环丙沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameCiprofloxacin
Drug Alias Name环丙氟哌酸Siprofloksasiini适普灵CiprofloksacinasCiprofloxacinum +[14] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsDNA topoisomerase inhibitors
TargetsBacterial DNA gyraseDNA topoisomerase
Therapy Area/IndicationsInhalational anthraxHospital-acquired pneumoniaLower Respiratory Tract Infections +[30] 
Global Approved IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsDiarrhea +[12] 
Approved Indications in ChinaUrinary Tract Infections
Original Approved Country/TerritoryJapan
Original Approved Date1987/01/01
Country/TerritoryCzechiaBulgariaCanada +[31] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMeiji Seika Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSavara IncGrifols SaMeiji Seika Pharma +[9] 
Inactive CompaniesAlk-Abello SaBayer Pharma AgAradigm Corporation +[8] 
Active IndicationsInhalational anthraxLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infections +[18] 
Inactive IndicationsHospital-acquired pneumoniaFebrile NeutropeniaOtitis Media +[12] 

Other Information

ATC CodeJ01MA02S01AE03S02AA15 +[4] 
Related LinksWikipediaDrugBankKEGG